

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of male gonad development (GO:2000020) | 9.84295271 |
| 2 | regulation of male gonad development (GO:2000018) | 9.51704811 |
| 3 | sex determination (GO:0007530) | 8.68052996 |
| 4 | androgen biosynthetic process (GO:0006702) | 7.93679450 |
| 5 | establishment of integrated proviral latency (GO:0075713) | 6.58531135 |
| 6 | estrogen biosynthetic process (GO:0006703) | 6.01406994 |
| 7 | establishment of viral latency (GO:0019043) | 5.63801387 |
| 8 | regulation of gonadotropin secretion (GO:0032276) | 5.50840092 |
| 9 | regulation of female gonad development (GO:2000194) | 5.49598693 |
| 10 | proteasome assembly (GO:0043248) | 5.18465413 |
| 11 | Leydig cell differentiation (GO:0033327) | 5.12480058 |
| 12 | ribosome assembly (GO:0042255) | 4.97639577 |
| 13 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.97530579 |
| 14 | sex differentiation (GO:0007548) | 4.89276413 |
| 15 | male sex determination (GO:0030238) | 4.77251600 |
| 16 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.73402564 |
| 17 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 4.67912784 |
| 18 | negative regulation of ligase activity (GO:0051352) | 4.51522544 |
| 19 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.51522544 |
| 20 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.49745086 |
| 21 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.43304341 |
| 22 | androgen metabolic process (GO:0008209) | 4.41589373 |
| 23 | cellular response to gonadotropin stimulus (GO:0071371) | 4.27412889 |
| 24 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.23586151 |
| 25 | mitotic metaphase plate congression (GO:0007080) | 4.22286118 |
| 26 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.16335704 |
| 27 | anatomical structure regression (GO:0060033) | 4.06635628 |
| 28 | IMP biosynthetic process (GO:0006188) | 4.03852863 |
| 29 | negative regulation of macrophage differentiation (GO:0045650) | 3.98150329 |
| 30 | metaphase plate congression (GO:0051310) | 3.93959510 |
| 31 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.93917931 |
| 32 | oocyte development (GO:0048599) | 3.93653758 |
| 33 | chromatin remodeling at centromere (GO:0031055) | 3.88270742 |
| 34 | CENP-A containing nucleosome assembly (GO:0034080) | 3.86350961 |
| 35 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.81044355 |
| 36 | adrenal gland development (GO:0030325) | 3.78322754 |
| 37 | cellular response to antibiotic (GO:0071236) | 3.77357257 |
| 38 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.77193957 |
| 39 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.74350955 |
| 40 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.74350955 |
| 41 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.74350955 |
| 42 | purine nucleobase biosynthetic process (GO:0009113) | 3.73196772 |
| 43 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.73009988 |
| 44 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.73009988 |
| 45 | positive regulation of ligase activity (GO:0051351) | 3.62923188 |
| 46 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.62049297 |
| 47 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.62049297 |
| 48 | IMP metabolic process (GO:0046040) | 3.61936408 |
| 49 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.61024147 |
| 50 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.58573697 |
| 51 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.57420478 |
| 52 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.54808586 |
| 53 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.54052900 |
| 54 | protein localization to kinetochore (GO:0034501) | 3.53743438 |
| 55 | chaperone-mediated protein transport (GO:0072321) | 3.52788572 |
| 56 | glomerular basement membrane development (GO:0032836) | 3.51491509 |
| 57 | regulation of mitochondrial translation (GO:0070129) | 3.50271220 |
| 58 | regulation of ligase activity (GO:0051340) | 3.46548211 |
| 59 | positive regulation of antigen processing and presentation (GO:0002579) | 3.45164868 |
| 60 | cullin deneddylation (GO:0010388) | 3.45016199 |
| 61 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.44076098 |
| 62 | negative regulation of sister chromatid segregation (GO:0033046) | 3.44076098 |
| 63 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.44076098 |
| 64 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.44076098 |
| 65 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.44076098 |
| 66 | spindle checkpoint (GO:0031577) | 3.43850965 |
| 67 | protein maturation by protein folding (GO:0022417) | 3.43677528 |
| 68 | rRNA modification (GO:0000154) | 3.43516417 |
| 69 | glomerulus development (GO:0032835) | 3.43268781 |
| 70 | L-serine metabolic process (GO:0006563) | 3.40997306 |
| 71 | negative regulation of chromosome segregation (GO:0051985) | 3.38094809 |
| 72 | mitotic spindle checkpoint (GO:0071174) | 3.36105942 |
| 73 | DNA replication checkpoint (GO:0000076) | 3.35938174 |
| 74 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.35159426 |
| 75 | DNA strand elongation (GO:0022616) | 3.34636867 |
| 76 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.34260715 |
| 77 | natural killer cell differentiation (GO:0001779) | 3.33413465 |
| 78 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.31812076 |
| 79 | cellular response to interferon-alpha (GO:0035457) | 3.29757596 |
| 80 | regulation of helicase activity (GO:0051095) | 3.29451303 |
| 81 | histone exchange (GO:0043486) | 3.28426996 |
| 82 | female gonad development (GO:0008585) | 3.28387067 |
| 83 | nucleobase biosynthetic process (GO:0046112) | 3.27227707 |
| 84 | ovulation cycle (GO:0042698) | 3.24477808 |
| 85 | hormone biosynthetic process (GO:0042446) | 3.23969380 |
| 86 | DNA damage response, detection of DNA damage (GO:0042769) | 3.23683020 |
| 87 | heterochromatin organization (GO:0070828) | 3.23528677 |
| 88 | regulation of natural killer cell differentiation (GO:0032823) | 3.23202779 |
| 89 | urogenital system development (GO:0001655) | 3.21858873 |
| 90 | protein deneddylation (GO:0000338) | 3.21695298 |
| 91 | negative regulation of protein ubiquitination (GO:0031397) | 3.20160975 |
| 92 | regulation of meiosis I (GO:0060631) | 3.18254773 |
| 93 | response to follicle-stimulating hormone (GO:0032354) | 3.15564219 |
| 94 | regulation of cellular amine metabolic process (GO:0033238) | 3.13967191 |
| 95 | establishment of chromosome localization (GO:0051303) | 3.12097567 |
| 96 | mitotic spindle assembly checkpoint (GO:0007094) | 3.11163648 |
| 97 | atrioventricular valve morphogenesis (GO:0003181) | 3.10705185 |
| 98 | spliceosomal snRNP assembly (GO:0000387) | 3.10443350 |
| 99 | positive regulation of reproductive process (GO:2000243) | 3.10415500 |
| 100 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.07831763 |
| 101 | termination of RNA polymerase III transcription (GO:0006386) | 3.07831763 |
| 102 | regulation of antigen processing and presentation (GO:0002577) | 3.04229295 |
| 103 | hemoglobin metabolic process (GO:0020027) | 3.04152923 |
| 104 | multicellular organismal aging (GO:0010259) | 3.03706981 |
| 105 | rRNA methylation (GO:0031167) | 3.02634092 |
| 106 | spindle assembly checkpoint (GO:0071173) | 3.02062904 |
| 107 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 3.01449198 |
| 108 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.99294995 |
| 109 | DNA replication-independent nucleosome organization (GO:0034724) | 2.99294995 |
| 110 | response to X-ray (GO:0010165) | 2.97989624 |
| 111 | negative regulation of mitosis (GO:0045839) | 2.96977445 |
| 112 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.96951999 |
| 113 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.96951999 |
| 114 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.96859271 |
| 115 | DNA double-strand break processing (GO:0000729) | 2.96337307 |
| 116 | tRNA aminoacylation for protein translation (GO:0006418) | 2.95537907 |
| 117 | dendritic cell chemotaxis (GO:0002407) | 2.95232628 |
| 118 | estrogen metabolic process (GO:0008210) | 2.95214659 |
| 119 | regulation of spindle organization (GO:0090224) | 2.95106371 |
| 120 | cellular response to toxic substance (GO:0097237) | 2.93250016 |
| 121 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.92307941 |
| 122 | cell cycle G1/S phase transition (GO:0044843) | 2.92307941 |
| 123 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.91522360 |
| 124 | regulation of chromosome segregation (GO:0051983) | 2.89972991 |
| 125 | AMP metabolic process (GO:0046033) | 2.89397608 |
| 126 | cell differentiation involved in metanephros development (GO:0072202) | 2.88396244 |
| 127 | tRNA aminoacylation (GO:0043039) | 2.88082994 |
| 128 | amino acid activation (GO:0043038) | 2.88082994 |
| 129 | regulation of sister chromatid segregation (GO:0033045) | 2.86735788 |
| 130 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.86735788 |
| 131 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.86735788 |
| 132 | protein targeting to mitochondrion (GO:0006626) | 2.86070676 |
| 133 | mitotic sister chromatid segregation (GO:0000070) | 2.83270530 |
| 134 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.82382482 |
| 135 | protein complex localization (GO:0031503) | 2.82346778 |
| 136 | ribosomal large subunit biogenesis (GO:0042273) | 2.81942094 |
| 137 | mesonephros development (GO:0001823) | 2.79710020 |
| 138 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.79575294 |
| 139 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.78522459 |
| 140 | ventricular cardiac muscle cell development (GO:0055015) | 2.78086981 |
| 141 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.77677223 |
| 142 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.77677223 |
| 143 | formation of translation preinitiation complex (GO:0001731) | 2.77410579 |
| 144 | response to interferon-alpha (GO:0035455) | 2.77345431 |
| 145 | telomere maintenance via recombination (GO:0000722) | 2.74462914 |
| 146 | ketone biosynthetic process (GO:0042181) | 2.74146899 |
| 147 | glucocorticoid biosynthetic process (GO:0006704) | 2.73168723 |
| 148 | ovulation cycle process (GO:0022602) | 2.72117806 |
| 149 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.66693912 |
| 150 | positive regulation of meiosis (GO:0045836) | 2.66256699 |
| 151 | regulation of activation of Janus kinase activity (GO:0010533) | 2.64780735 |
| 152 | Sertoli cell development (GO:0060009) | 2.64131161 |
| 153 | embryonic digestive tract morphogenesis (GO:0048557) | 2.63673352 |
| 154 | seminiferous tubule development (GO:0072520) | 2.63474422 |
| 155 | male gonad development (GO:0008584) | 2.63251315 |
| 156 | response to gonadotropin (GO:0034698) | 2.60755368 |
| 157 | histone H3-K36 demethylation (GO:0070544) | 2.60262634 |
| 158 | male genitalia development (GO:0030539) | 2.59426250 |
| 159 | astrocyte development (GO:0014002) | 2.58719556 |
| 160 | DNA integration (GO:0015074) | 2.58609200 |
| 161 | regulation of timing of cell differentiation (GO:0048505) | 2.57952767 |
| 162 | detection of bacterium (GO:0016045) | 2.56930473 |
| 163 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.55548433 |
| 164 | cornea development in camera-type eye (GO:0061303) | 2.55515104 |
| 165 | cellular response to exogenous dsRNA (GO:0071360) | 2.54674743 |
| 166 | positive regulation of meiotic cell cycle (GO:0051446) | 2.54290136 |
| 167 | protein heterotrimerization (GO:0070208) | 2.50973559 |
| 168 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.47871264 |
| 169 | nephron tubule formation (GO:0072079) | 2.47676586 |
| 170 | detection of other organism (GO:0098543) | 2.47416346 |
| 171 | daunorubicin metabolic process (GO:0044597) | 2.46949107 |
| 172 | polyketide metabolic process (GO:0030638) | 2.46949107 |
| 173 | doxorubicin metabolic process (GO:0044598) | 2.46949107 |
| 174 | negative regulation of B cell activation (GO:0050869) | 2.45726306 |
| 175 | superoxide anion generation (GO:0042554) | 2.44966556 |
| 176 | regulation of skeletal muscle contraction (GO:0014819) | 2.41457215 |
| 177 | synapsis (GO:0007129) | 2.40961804 |
| 178 | regulation of macrophage differentiation (GO:0045649) | 2.40602891 |
| 179 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.39363260 |
| 180 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.39363260 |
| 181 | regulation of B cell differentiation (GO:0045577) | 2.38541112 |
| 182 | microglial cell activation (GO:0001774) | 2.38304315 |
| 183 | natural killer cell activation (GO:0030101) | 2.37639574 |
| 184 | dendritic cell migration (GO:0036336) | 2.37439927 |
| 185 | negative regulation of reproductive process (GO:2000242) | 2.36688687 |
| 186 | ribosomal small subunit assembly (GO:0000028) | 2.35457201 |
| 187 | positive regulation of interleukin-17 production (GO:0032740) | 2.35332292 |
| 188 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.34156081 |
| 189 | T-helper 1 type immune response (GO:0042088) | 2.33836498 |
| 190 | regulation of neutrophil migration (GO:1902622) | 2.33527596 |
| 191 | regulation of neutrophil chemotaxis (GO:0090022) | 2.33527596 |
| 192 | piRNA metabolic process (GO:0034587) | 2.32810518 |
| 193 | type I interferon signaling pathway (GO:0060337) | 2.32778239 |
| 194 | cellular response to type I interferon (GO:0071357) | 2.32778239 |
| 195 | maintenance of protein location in nucleus (GO:0051457) | 2.32752144 |
| 196 | positive regulation of natural killer cell activation (GO:0032816) | 2.32593797 |
| 197 | ovarian follicle development (GO:0001541) | 2.31036405 |
| 198 | positive regulation of defense response to virus by host (GO:0002230) | 2.30396888 |
| 199 | gonad development (GO:0008406) | 2.28839827 |
| 200 | gonadal mesoderm development (GO:0007506) | 17.8818741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.99298708 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.57128998 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.75576240 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.72053868 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.42159585 |
| 6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.41053024 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.31917232 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.29716754 |
| 9 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.27017171 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.22830573 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.22616214 |
| 12 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.17423330 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.15128186 |
| 14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.07199833 |
| 15 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.06263173 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.93932067 |
| 17 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.92822900 |
| 18 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.88260822 |
| 19 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.83217578 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.81019318 |
| 21 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.70597886 |
| 22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.66153790 |
| 23 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.65360788 |
| 24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.63651527 |
| 25 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.60649332 |
| 26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.58112762 |
| 27 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 2.53990734 |
| 28 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.53640866 |
| 29 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.53180435 |
| 30 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.43496707 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.42514997 |
| 32 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.38469328 |
| 33 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.35886907 |
| 34 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.29991964 |
| 35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.25081571 |
| 36 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.21762546 |
| 37 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.19249562 |
| 38 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.18734697 |
| 39 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.18069509 |
| 40 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.08839148 |
| 41 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.06597116 |
| 42 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.01756106 |
| 43 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.99714371 |
| 44 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.96398996 |
| 45 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.95735587 |
| 46 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.94370454 |
| 47 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.92670709 |
| 48 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.91533033 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.91422738 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.88823321 |
| 51 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.87505753 |
| 52 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.86665489 |
| 53 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.86010700 |
| 54 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84835175 |
| 55 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.79661728 |
| 56 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.77950279 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77621963 |
| 58 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.76847060 |
| 59 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.76100370 |
| 60 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.75685546 |
| 61 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.74404594 |
| 62 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.74250582 |
| 63 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.74058293 |
| 64 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.73766685 |
| 65 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.72393998 |
| 66 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.71628386 |
| 67 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.71059364 |
| 68 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.70481099 |
| 69 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.70002567 |
| 70 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.69158043 |
| 71 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.68168564 |
| 72 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.68159197 |
| 73 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.65628769 |
| 74 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.64704745 |
| 75 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.64593650 |
| 76 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.63649267 |
| 77 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.62886245 |
| 78 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.62886245 |
| 79 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.62776433 |
| 80 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.61169146 |
| 81 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.60326163 |
| 82 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.60296706 |
| 83 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.60246310 |
| 84 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.59782251 |
| 85 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.59033811 |
| 86 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.58266491 |
| 87 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.56336056 |
| 88 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.56053813 |
| 89 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.56043533 |
| 90 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.55633405 |
| 91 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.54880270 |
| 92 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.53845859 |
| 93 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.53842508 |
| 94 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.52012080 |
| 95 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.50545402 |
| 96 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.49272521 |
| 97 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.49132330 |
| 98 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.47514535 |
| 99 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.45694066 |
| 100 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.45378300 |
| 101 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45235166 |
| 102 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.39393298 |
| 103 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.39393298 |
| 104 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.38645750 |
| 105 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.37923000 |
| 106 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.37524103 |
| 107 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.37396493 |
| 108 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.37285643 |
| 109 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.37239396 |
| 110 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.36621029 |
| 111 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.36420241 |
| 112 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.35355281 |
| 113 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.33554810 |
| 114 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.33112416 |
| 115 | TP53_16413492_ChIP-PET_HCT116_Human | 1.32215503 |
| 116 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.31891476 |
| 117 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.31791382 |
| 118 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30950834 |
| 119 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.29235628 |
| 120 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.27932992 |
| 121 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27832197 |
| 122 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.26652484 |
| 123 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25767527 |
| 124 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.25480251 |
| 125 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.25236919 |
| 126 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.25225418 |
| 127 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.25171112 |
| 128 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.23143372 |
| 129 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.21588023 |
| 130 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18969627 |
| 131 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.18940155 |
| 132 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.18767824 |
| 133 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.18454198 |
| 134 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.18297426 |
| 135 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18064447 |
| 136 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.16721921 |
| 137 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.15927511 |
| 138 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15614207 |
| 139 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.15002777 |
| 140 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.14682039 |
| 141 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.13766153 |
| 142 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.12832894 |
| 143 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.11944454 |
| 144 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.11675439 |
| 145 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.10220828 |
| 146 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.09956552 |
| 147 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.09683960 |
| 148 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.09210447 |
| 149 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.09191052 |
| 150 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.08823100 |
| 151 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08606337 |
| 152 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.08233563 |
| 153 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.06618700 |
| 154 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.06585210 |
| 155 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06515082 |
| 156 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05332037 |
| 157 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04131106 |
| 158 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04131106 |
| 159 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.03440715 |
| 160 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.02718027 |
| 161 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.01350355 |
| 162 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.01250352 |
| 163 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.00947417 |
| 164 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.00375750 |
| 165 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.00047016 |
| 166 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99855003 |
| 167 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.98688842 |
| 168 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98647045 |
| 169 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.97823947 |
| 170 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.97542357 |
| 171 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.96729077 |
| 172 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.96363277 |
| 173 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.95496256 |
| 174 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.94962938 |
| 175 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93203501 |
| 176 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92201351 |
| 177 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.91661687 |
| 178 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.90850061 |
| 179 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.90706174 |
| 180 | VDR_22108803_ChIP-Seq_LS180_Human | 0.90286227 |
| 181 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.89327438 |
| 182 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.89023101 |
| 183 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.88222486 |
| 184 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.87784116 |
| 185 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87067728 |
| 186 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.86689662 |
| 187 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83680641 |
| 188 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83454272 |
| 189 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.82637202 |
| 190 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.81019750 |
| 191 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.80615351 |
| 192 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.80006432 |
| 193 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.77972753 |
| 194 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.77503433 |
| 195 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.76857885 |
| 196 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.76387138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008995_early_reproductive_senescence | 6.27677411 |
| 2 | MP0003693_abnormal_embryo_hatching | 4.53451335 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 3.90234439 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.47800742 |
| 5 | MP0005377_hearing/vestibular/ear_phenot | 3.45354478 |
| 6 | MP0003878_abnormal_ear_physiology | 3.45354478 |
| 7 | MP0010094_abnormal_chromosome_stability | 3.26669674 |
| 8 | MP0009379_abnormal_foot_pigmentation | 3.15976826 |
| 9 | MP0008058_abnormal_DNA_repair | 3.12138718 |
| 10 | MP0005171_absent_coat_pigmentation | 3.00190022 |
| 11 | MP0003111_abnormal_nucleus_morphology | 2.99059720 |
| 12 | MP0008932_abnormal_embryonic_tissue | 2.87821906 |
| 13 | MP0003123_paternal_imprinting | 2.86778567 |
| 14 | MP0003718_maternal_effect | 2.76483036 |
| 15 | MP0003077_abnormal_cell_cycle | 2.73333963 |
| 16 | MP0008007_abnormal_cellular_replicative | 2.65876518 |
| 17 | MP0004147_increased_porphyrin_level | 2.63729360 |
| 18 | MP0009697_abnormal_copulation | 2.58907079 |
| 19 | MP0009384_cardiac_valve_regurgitation | 2.57375524 |
| 20 | MP0010352_gastrointestinal_tract_polyps | 2.54310944 |
| 21 | MP0005647_abnormal_sex_gland | 2.53006710 |
| 22 | MP0003315_abnormal_perineum_morphology | 2.32023303 |
| 23 | MP0001835_abnormal_antigen_presentation | 2.27099544 |
| 24 | MP0005671_abnormal_response_to | 2.17669454 |
| 25 | MP0009278_abnormal_bone_marrow | 2.13789175 |
| 26 | MP0001873_stomach_inflammation | 2.10471150 |
| 27 | MP0000685_abnormal_immune_system | 2.04315820 |
| 28 | MP0010030_abnormal_orbit_morphology | 2.01309570 |
| 29 | MP0002102_abnormal_ear_morphology | 2.01188389 |
| 30 | MP0003136_yellow_coat_color | 2.00826231 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.98400394 |
| 32 | MP0000566_synostosis | 1.97872857 |
| 33 | MP0001188_hyperpigmentation | 1.96958638 |
| 34 | MP0003786_premature_aging | 1.92014814 |
| 35 | MP0001730_embryonic_growth_arrest | 1.81541054 |
| 36 | MP0009672_abnormal_birth_weight | 1.79203909 |
| 37 | MP0003890_abnormal_embryonic-extraembry | 1.76986589 |
| 38 | MP0002009_preneoplasia | 1.73423055 |
| 39 | MP0005389_reproductive_system_phenotype | 1.72529741 |
| 40 | MP0001666_abnormal_nutrient_absorption | 1.71333161 |
| 41 | MP0001293_anophthalmia | 1.69728505 |
| 42 | MP0002163_abnormal_gland_morphology | 1.67520389 |
| 43 | MP0003950_abnormal_plasma_membrane | 1.63532619 |
| 44 | MP0002160_abnormal_reproductive_system | 1.60972641 |
| 45 | MP0001958_emphysema | 1.60495707 |
| 46 | MP0000350_abnormal_cell_proliferation | 1.60415324 |
| 47 | MP0002210_abnormal_sex_determination | 1.56387840 |
| 48 | MP0003195_calcinosis | 1.56284516 |
| 49 | MP0003119_abnormal_digestive_system | 1.54688194 |
| 50 | MP0001346_abnormal_lacrimal_gland | 1.49714859 |
| 51 | MP0003566_abnormal_cell_adhesion | 1.49381671 |
| 52 | MP0003941_abnormal_skin_development | 1.49054124 |
| 53 | MP0002796_impaired_skin_barrier | 1.47730379 |
| 54 | MP0001919_abnormal_reproductive_system | 1.46584469 |
| 55 | MP0008877_abnormal_DNA_methylation | 1.43106629 |
| 56 | MP0005379_endocrine/exocrine_gland_phen | 1.42467414 |
| 57 | MP0001853_heart_inflammation | 1.41594635 |
| 58 | MP0005257_abnormal_intraocular_pressure | 1.41476876 |
| 59 | MP0003937_abnormal_limbs/digits/tail_de | 1.40015023 |
| 60 | MP0003186_abnormal_redox_activity | 1.39429809 |
| 61 | MP0001790_abnormal_immune_system | 1.37364456 |
| 62 | MP0005387_immune_system_phenotype | 1.37364456 |
| 63 | MP0000613_abnormal_salivary_gland | 1.35954643 |
| 64 | MP0002132_abnormal_respiratory_system | 1.34026899 |
| 65 | MP0001485_abnormal_pinna_reflex | 1.33193789 |
| 66 | MP0003763_abnormal_thymus_physiology | 1.31947930 |
| 67 | MP0001697_abnormal_embryo_size | 1.31436830 |
| 68 | MP0002085_abnormal_embryonic_tissue | 1.30005515 |
| 69 | MP0002084_abnormal_developmental_patter | 1.29061641 |
| 70 | MP0005380_embryogenesis_phenotype | 1.28615270 |
| 71 | MP0001672_abnormal_embryogenesis/_devel | 1.28615270 |
| 72 | MP0005174_abnormal_tail_pigmentation | 1.28424450 |
| 73 | MP0005310_abnormal_salivary_gland | 1.28414230 |
| 74 | MP0006036_abnormal_mitochondrial_physio | 1.28005136 |
| 75 | MP0006292_abnormal_olfactory_placode | 1.26792598 |
| 76 | MP0002938_white_spotting | 1.26060710 |
| 77 | MP0008789_abnormal_olfactory_epithelium | 1.25809057 |
| 78 | MP0005645_abnormal_hypothalamus_physiol | 1.25349847 |
| 79 | MP0000631_abnormal_neuroendocrine_gland | 1.25050781 |
| 80 | MP0002080_prenatal_lethality | 1.23730137 |
| 81 | MP0000470_abnormal_stomach_morphology | 1.23387723 |
| 82 | MP0004272_abnormal_basement_membrane | 1.22697567 |
| 83 | MP0000372_irregular_coat_pigmentation | 1.22012631 |
| 84 | MP0006035_abnormal_mitochondrial_morpho | 1.21356065 |
| 85 | MP0002452_abnormal_antigen_presenting | 1.21083345 |
| 86 | MP0003567_abnormal_fetal_cardiomyocyte | 1.21075664 |
| 87 | MP0000015_abnormal_ear_pigmentation | 1.20193052 |
| 88 | MP0001661_extended_life_span | 1.19496982 |
| 89 | MP0003045_fibrosis | 1.19468551 |
| 90 | MP0001119_abnormal_female_reproductive | 1.18875256 |
| 91 | MP0001145_abnormal_male_reproductive | 1.17984740 |
| 92 | MP0003936_abnormal_reproductive_system | 1.17155007 |
| 93 | MP0000762_abnormal_tongue_morphology | 1.14364904 |
| 94 | MP0001800_abnormal_humoral_immune | 1.13848657 |
| 95 | MP0004019_abnormal_vitamin_homeostasis | 1.13592693 |
| 96 | MP0009785_altered_susceptibility_to | 1.13066608 |
| 97 | MP0002233_abnormal_nose_morphology | 1.12248791 |
| 98 | MP0000537_abnormal_urethra_morphology | 1.10615686 |
| 99 | MP0010234_abnormal_vibrissa_follicle | 1.10179785 |
| 100 | MP0001819_abnormal_immune_cell | 1.09650440 |
| 101 | MP0000569_abnormal_digit_pigmentation | 1.09554896 |
| 102 | MP0005365_abnormal_bile_salt | 1.09173489 |
| 103 | MP0002420_abnormal_adaptive_immunity | 1.08832676 |
| 104 | MP0005000_abnormal_immune_tolerance | 1.08762364 |
| 105 | MP0003121_genomic_imprinting | 1.07509349 |
| 106 | MP0002419_abnormal_innate_immunity | 1.06927274 |
| 107 | MP0003984_embryonic_growth_retardation | 1.06708777 |
| 108 | MP0005670_abnormal_white_adipose | 1.05896229 |
| 109 | MP0002088_abnormal_embryonic_growth/wei | 1.05140972 |
| 110 | MP0000681_abnormal_thyroid_gland | 1.04882838 |
| 111 | MP0008057_abnormal_DNA_replication | 1.04775073 |
| 112 | MP0005025_abnormal_response_to | 1.04474762 |
| 113 | MP0004742_abnormal_vestibular_system | 1.04426014 |
| 114 | MP0002111_abnormal_tail_morphology | 1.04180808 |
| 115 | MP0005408_hypopigmentation | 1.03842586 |
| 116 | MP0000579_abnormal_nail_morphology | 1.03292487 |
| 117 | MP0005395_other_phenotype | 1.02108417 |
| 118 | MP0009333_abnormal_splenocyte_physiolog | 1.00951332 |
| 119 | MP0009780_abnormal_chondrocyte_physiolo | 1.00918518 |
| 120 | MP0000383_abnormal_hair_follicle | 1.00544981 |
| 121 | MP0002254_reproductive_system_inflammat | 0.99428177 |
| 122 | MP0001929_abnormal_gametogenesis | 0.99139611 |
| 123 | MP0005501_abnormal_skin_physiology | 0.98540932 |
| 124 | MP0005409_darkened_coat_color | 0.98247132 |
| 125 | MP0008875_abnormal_xenobiotic_pharmacok | 0.97826467 |
| 126 | MP0005360_urolithiasis | 0.96231515 |
| 127 | MP0002697_abnormal_eye_size | 0.95986129 |
| 128 | MP0000653_abnormal_sex_gland | 0.95878316 |
| 129 | MP0001881_abnormal_mammary_gland | 0.95562647 |
| 130 | MP0004197_abnormal_fetal_growth/weight/ | 0.94979980 |
| 131 | MP0005367_renal/urinary_system_phenotyp | 0.94841273 |
| 132 | MP0000516_abnormal_urinary_system | 0.94841273 |
| 133 | MP0005332_abnormal_amino_acid | 0.94808692 |
| 134 | MP0000639_abnormal_adrenal_gland | 0.94394779 |
| 135 | MP0002723_abnormal_immune_serum | 0.89485836 |
| 136 | MP0002086_abnormal_extraembryonic_tissu | 0.88568608 |
| 137 | MP0004264_abnormal_extraembryonic_tissu | 0.88538062 |
| 138 | MP0001286_abnormal_eye_development | 0.88155543 |
| 139 | MP0001529_abnormal_vocalization | 0.87881969 |
| 140 | MP0001664_abnormal_digestion | 0.87768046 |
| 141 | MP0003866_abnormal_defecation | 0.87232183 |
| 142 | MP0009703_decreased_birth_body | 0.86718254 |
| 143 | MP0010155_abnormal_intestine_physiology | 0.86389224 |
| 144 | MP0000358_abnormal_cell_content/ | 0.85374557 |
| 145 | MP0001663_abnormal_digestive_system | 0.85216276 |
| 146 | MP0000313_abnormal_cell_death | 0.85183157 |
| 147 | MP0003879_abnormal_hair_cell | 0.84837087 |
| 148 | MP0005499_abnormal_olfactory_system | 0.83617776 |
| 149 | MP0005394_taste/olfaction_phenotype | 0.83617776 |
| 150 | MP0002095_abnormal_skin_pigmentation | 0.83545586 |
| 151 | MP0000049_abnormal_middle_ear | 0.82135686 |
| 152 | MP0001299_abnormal_eye_distance/ | 0.81616854 |
| 153 | MP0001545_abnormal_hematopoietic_system | 0.80464795 |
| 154 | MP0005397_hematopoietic_system_phenotyp | 0.80464795 |
| 155 | MP0005248_abnormal_Harderian_gland | 0.79368099 |
| 156 | MP0005085_abnormal_gallbladder_physiolo | 0.79136960 |
| 157 | MP0002396_abnormal_hematopoietic_system | 0.78220735 |
| 158 | MP0002060_abnormal_skin_morphology | 0.77655702 |
| 159 | MP0003828_pulmonary_edema | 0.77155224 |
| 160 | MP0005381_digestive/alimentary_phenotyp | 0.76221386 |
| 161 | MP0005503_abnormal_tendon_morphology | 0.75986588 |
| 162 | MP0000490_abnormal_crypts_of | 0.75705850 |
| 163 | MP0002876_abnormal_thyroid_physiology | 0.75555915 |
| 164 | MP0001849_ear_inflammation | 0.75329223 |
| 165 | MP0002405_respiratory_system_inflammati | 0.74644730 |
| 166 | MP0010307_abnormal_tumor_latency | 0.74265462 |
| 167 | MP0002277_abnormal_respiratory_mucosa | 0.73942743 |
| 168 | MP0001764_abnormal_homeostasis | 0.73351841 |
| 169 | MP0003698_abnormal_male_reproductive | 0.72177764 |
| 170 | MP0000647_abnormal_sebaceous_gland | 0.71435695 |
| 171 | MP0002098_abnormal_vibrissa_morphology | 0.71285422 |
| 172 | MP0003724_increased_susceptibility_to | 0.71039441 |
| 173 | MP0003300_gastrointestinal_ulcer | 0.70091638 |
| 174 | MP0004133_heterotaxia | 0.69379218 |
| 175 | MP0005330_cardiomyopathy | 0.68932035 |
| 176 | MP0002090_abnormal_vision | 0.67569256 |
| 177 | MP0002398_abnormal_bone_marrow | 0.67139167 |
| 178 | MP0002168_other_aberrant_phenotype | 0.66977929 |
| 179 | MP0000627_abnormal_mammary_gland | 0.66571990 |
| 180 | MP0003122_maternal_imprinting | 0.66317819 |
| 181 | MP0000751_myopathy | 0.66197666 |
| 182 | MP0003868_abnormal_feces_composition | 0.62806067 |
| 183 | MP0005384_cellular_phenotype | 0.61959891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gonadal dysgenesis (HP:0000133) | 8.82996338 |
| 2 | Abnormal sex determination (HP:0012244) | 6.93027550 |
| 3 | Sex reversal (HP:0012245) | 6.93027550 |
| 4 | Male pseudohermaphroditism (HP:0000037) | 6.43938541 |
| 5 | Gonadotropin excess (HP:0000837) | 5.85256619 |
| 6 | Testicular neoplasm (HP:0010788) | 5.16032114 |
| 7 | Male infertility (HP:0003251) | 4.93241061 |
| 8 | Abnormality of male internal genitalia (HP:0000022) | 4.37927038 |
| 9 | Azoospermia (HP:0000027) | 4.10068055 |
| 10 | Hypoplastic left heart (HP:0004383) | 4.09800694 |
| 11 | Hypoplasia of the uterus (HP:0000013) | 3.85237670 |
| 12 | Aplasia/hypoplasia of the uterus (HP:0008684) | 3.60729107 |
| 13 | Reduced antithrombin III activity (HP:0001976) | 3.35028955 |
| 14 | Abnormality of the labia minora (HP:0012880) | 3.34703748 |
| 15 | Increased hepatocellular lipid droplets (HP:0006565) | 3.34452688 |
| 16 | Increased serum pyruvate (HP:0003542) | 3.32478052 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 3.31093014 |
| 18 | Abnormal spermatogenesis (HP:0008669) | 3.23240939 |
| 19 | Hypoplastic heart (HP:0001961) | 3.12763007 |
| 20 | Abnormality of glycolysis (HP:0004366) | 3.11547587 |
| 21 | Acute encephalopathy (HP:0006846) | 3.10770933 |
| 22 | Germ cell neoplasia (HP:0100728) | 3.10441719 |
| 23 | Hypoglycemic seizures (HP:0002173) | 3.08461367 |
| 24 | Acute necrotizing encephalopathy (HP:0006965) | 3.07873882 |
| 25 | Abnormality of serum amino acid levels (HP:0003112) | 2.98994968 |
| 26 | Lipid accumulation in hepatocytes (HP:0006561) | 2.98881166 |
| 27 | Type I transferrin isoform profile (HP:0003642) | 2.94833596 |
| 28 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.84483941 |
| 29 | Onycholysis (HP:0001806) | 2.82372397 |
| 30 | Methylmalonic acidemia (HP:0002912) | 2.81612502 |
| 31 | Colon cancer (HP:0003003) | 2.80895281 |
| 32 | Pulmonary fibrosis (HP:0002206) | 2.76590738 |
| 33 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.73925915 |
| 34 | Hyperglycinemia (HP:0002154) | 2.68857072 |
| 35 | Methylmalonic aciduria (HP:0012120) | 2.68465915 |
| 36 | Follicular hyperkeratosis (HP:0007502) | 2.66712866 |
| 37 | Symptomatic seizures (HP:0011145) | 2.66099938 |
| 38 | Mitochondrial inheritance (HP:0001427) | 2.63312113 |
| 39 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.63168864 |
| 40 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.63035060 |
| 41 | Hypoglycemic coma (HP:0001325) | 2.62811749 |
| 42 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.61108616 |
| 43 | Increased CSF lactate (HP:0002490) | 2.60836011 |
| 44 | Rough bone trabeculation (HP:0100670) | 2.56373093 |
| 45 | Progressive macrocephaly (HP:0004481) | 2.54567898 |
| 46 | Pulmonary artery stenosis (HP:0004415) | 2.52575334 |
| 47 | Abnormal protein glycosylation (HP:0012346) | 2.52022173 |
| 48 | Abnormal glycosylation (HP:0012345) | 2.52022173 |
| 49 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.52022173 |
| 50 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.52022173 |
| 51 | Sparse eyelashes (HP:0000653) | 2.51110550 |
| 52 | Spastic diplegia (HP:0001264) | 2.45295682 |
| 53 | Multiple enchondromatosis (HP:0005701) | 2.43604184 |
| 54 | Hepatocellular necrosis (HP:0001404) | 2.42251561 |
| 55 | Dry hair (HP:0011359) | 2.41243167 |
| 56 | Cerebral edema (HP:0002181) | 2.39796589 |
| 57 | Birth length less than 3rd percentile (HP:0003561) | 2.39079735 |
| 58 | Asplenia (HP:0001746) | 2.38647739 |
| 59 | Chromsome breakage (HP:0040012) | 2.38529447 |
| 60 | Agammaglobulinemia (HP:0004432) | 2.37943153 |
| 61 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.35859122 |
| 62 | Ankle contracture (HP:0006466) | 2.34557079 |
| 63 | Intrahepatic cholestasis (HP:0001406) | 2.33804829 |
| 64 | Prominent metopic ridge (HP:0005487) | 2.31382479 |
| 65 | Abnormality of the preputium (HP:0100587) | 2.31326436 |
| 66 | Renal Fanconi syndrome (HP:0001994) | 2.30689807 |
| 67 | Anomalous pulmonary venous return (HP:0010772) | 2.29169037 |
| 68 | Abnormality of the axillary hair (HP:0100134) | 2.28556543 |
| 69 | Abnormality of secondary sexual hair (HP:0009888) | 2.28556543 |
| 70 | Megaloblastic anemia (HP:0001889) | 2.26589802 |
| 71 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.25573142 |
| 72 | Infertility (HP:0000789) | 2.24495350 |
| 73 | Microglossia (HP:0000171) | 2.24338302 |
| 74 | Meckel diverticulum (HP:0002245) | 2.23271264 |
| 75 | 11 pairs of ribs (HP:0000878) | 2.22403825 |
| 76 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.22121331 |
| 77 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.22121331 |
| 78 | Aplasia cutis congenita (HP:0001057) | 2.21958860 |
| 79 | Selective tooth agenesis (HP:0001592) | 2.21576311 |
| 80 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.20124153 |
| 81 | Reticulocytopenia (HP:0001896) | 2.18806508 |
| 82 | Hepatic necrosis (HP:0002605) | 2.18507755 |
| 83 | Hypoplastic female external genitalia (HP:0012815) | 2.17962206 |
| 84 | Abnormality of glycine metabolism (HP:0010895) | 2.17833142 |
| 85 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.17833142 |
| 86 | Postnatal microcephaly (HP:0005484) | 2.17479014 |
| 87 | Hypobetalipoproteinemia (HP:0003563) | 2.17434217 |
| 88 | Facial cleft (HP:0002006) | 2.16721940 |
| 89 | Gastrointestinal infarctions (HP:0005244) | 2.16316789 |
| 90 | True hermaphroditism (HP:0010459) | 2.14957987 |
| 91 | Recurrent lower respiratory tract infections (HP:0002783) | 2.14042883 |
| 92 | Abnormality of the pulmonary veins (HP:0011718) | 2.12995388 |
| 93 | Neoplasm of the adrenal gland (HP:0100631) | 2.12207779 |
| 94 | Mediastinal lymphadenopathy (HP:0100721) | 2.12186525 |
| 95 | Increased serum lactate (HP:0002151) | 2.11572668 |
| 96 | Short middle phalanx of the 5th finger (HP:0004220) | 2.11289951 |
| 97 | Prolonged partial thromboplastin time (HP:0003645) | 2.11051390 |
| 98 | Abnormality of chromosome stability (HP:0003220) | 2.10698163 |
| 99 | Abnormal trabecular bone morphology (HP:0100671) | 2.09579295 |
| 100 | Stenosis of the external auditory canal (HP:0000402) | 2.09296410 |
| 101 | Transposition of the great arteries (HP:0001669) | 2.07762021 |
| 102 | Abnormal connection of the cardiac segments (HP:0011545) | 2.07762021 |
| 103 | Abnormal ventriculo-arterial connection (HP:0011563) | 2.07762021 |
| 104 | Chronic bronchitis (HP:0004469) | 2.06343008 |
| 105 | Right ventricular cardiomyopathy (HP:0011663) | 2.05878086 |
| 106 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.05544378 |
| 107 | Nausea (HP:0002018) | 2.05422229 |
| 108 | Median cleft lip (HP:0000161) | 2.05389302 |
| 109 | Hyperpituitarism (HP:0010514) | 2.05166338 |
| 110 | Abnormality of the ileum (HP:0001549) | 2.03222566 |
| 111 | Rectal prolapse (HP:0002035) | 2.02904466 |
| 112 | Oral leukoplakia (HP:0002745) | 2.02114227 |
| 113 | Secondary amenorrhea (HP:0000869) | 2.01644235 |
| 114 | Mesangial abnormality (HP:0001966) | 2.00553902 |
| 115 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.98974933 |
| 116 | Palpitations (HP:0001962) | 1.98436081 |
| 117 | Recurrent pneumonia (HP:0006532) | 1.97122945 |
| 118 | Abnormality of vitamin B metabolism (HP:0004340) | 1.95705796 |
| 119 | Ependymoma (HP:0002888) | 1.94818115 |
| 120 | Retrobulbar optic neuritis (HP:0100654) | 1.94468903 |
| 121 | Optic neuritis (HP:0100653) | 1.94468903 |
| 122 | Vascular calcification (HP:0004934) | 1.94039461 |
| 123 | Duplicated collecting system (HP:0000081) | 1.94013246 |
| 124 | Female pseudohermaphroditism (HP:0010458) | 1.93340675 |
| 125 | Ectopic kidney (HP:0000086) | 1.92526793 |
| 126 | Exercise intolerance (HP:0003546) | 1.91192305 |
| 127 | Adrenal hypoplasia (HP:0000835) | 1.91127727 |
| 128 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.90978490 |
| 129 | Lethargy (HP:0001254) | 1.90212798 |
| 130 | Primary adrenal insufficiency (HP:0008207) | 1.89484180 |
| 131 | Exertional dyspnea (HP:0002875) | 1.89071420 |
| 132 | Lactic acidosis (HP:0003128) | 1.88706741 |
| 133 | Fragile skin (HP:0001030) | 1.87637477 |
| 134 | Gastrointestinal stroma tumor (HP:0100723) | 1.86490408 |
| 135 | Conical tooth (HP:0000698) | 1.86321064 |
| 136 | Hypoplastic pelvis (HP:0008839) | 1.85899713 |
| 137 | Small intestinal stenosis (HP:0012848) | 1.85626887 |
| 138 | Duodenal stenosis (HP:0100867) | 1.85626887 |
| 139 | Primary amenorrhea (HP:0000786) | 1.84668470 |
| 140 | Shoulder girdle muscle weakness (HP:0003547) | 1.84118855 |
| 141 | Increased intramyocellular lipid droplets (HP:0012240) | 1.83224131 |
| 142 | Cerebral hypomyelination (HP:0006808) | 1.82841774 |
| 143 | Abnormality of the labia (HP:0000058) | 1.81721031 |
| 144 | Abnormality of the metopic suture (HP:0005556) | 1.80888691 |
| 145 | Recurrent sinusitis (HP:0011108) | 1.80560841 |
| 146 | Biliary tract neoplasm (HP:0100574) | 1.77583874 |
| 147 | Embryonal renal neoplasm (HP:0011794) | 1.77057054 |
| 148 | Prostate neoplasm (HP:0100787) | 1.76933338 |
| 149 | Gout (HP:0001997) | 1.76927673 |
| 150 | Abnormality of incisor morphology (HP:0011063) | 1.76747587 |
| 151 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.76363527 |
| 152 | Labial hypoplasia (HP:0000066) | 1.75714555 |
| 153 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.75623569 |
| 154 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.75623569 |
| 155 | Abnormality of the renal collecting system (HP:0004742) | 1.75454024 |
| 156 | Rhabdomyosarcoma (HP:0002859) | 1.74416470 |
| 157 | Hyperglycinuria (HP:0003108) | 1.74127451 |
| 158 | Orchitis (HP:0100796) | 1.72298706 |
| 159 | Abnormal lung lobation (HP:0002101) | 1.71821534 |
| 160 | Premature ovarian failure (HP:0008209) | 1.71382132 |
| 161 | Abnormal number of erythroid precursors (HP:0012131) | 1.71374342 |
| 162 | Recurrent abscess formation (HP:0002722) | 1.70153982 |
| 163 | Stage 5 chronic kidney disease (HP:0003774) | 1.69164750 |
| 164 | Myositis (HP:0100614) | 1.68884115 |
| 165 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.67354047 |
| 166 | Recurrent cutaneous fungal infections (HP:0011370) | 1.67354047 |
| 167 | Meningitis (HP:0001287) | 1.67057680 |
| 168 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.65302900 |
| 169 | Midline defect of the nose (HP:0004122) | 1.63315130 |
| 170 | Tongue fasciculations (HP:0001308) | 1.62369695 |
| 171 | IgM deficiency (HP:0002850) | 1.61699612 |
| 172 | Basal ganglia calcification (HP:0002135) | 1.60578408 |
| 173 | Porencephaly (HP:0002132) | 1.58201849 |
| 174 | Recurrent bronchitis (HP:0002837) | 1.57414120 |
| 175 | Abnormality of molar (HP:0011077) | 1.56606939 |
| 176 | Abnormality of molar morphology (HP:0011070) | 1.56606939 |
| 177 | Bifid tongue (HP:0010297) | 1.56152398 |
| 178 | Craniofacial hyperostosis (HP:0004493) | 1.55018596 |
| 179 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.54826726 |
| 180 | Nasolacrimal duct obstruction (HP:0000579) | 1.54447345 |
| 181 | Hypergonadotropic hypogonadism (HP:0000815) | 1.54256875 |
| 182 | Premature loss of primary teeth (HP:0006323) | 1.53220739 |
| 183 | Aortic valve stenosis (HP:0001650) | 1.52360559 |
| 184 | Duplication of thumb phalanx (HP:0009942) | 1.51496714 |
| 185 | Stomach cancer (HP:0012126) | 1.50864145 |
| 186 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.50677278 |
| 187 | Petechiae (HP:0000967) | 1.50496023 |
| 188 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.50466644 |
| 189 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.50315055 |
| 190 | Absent/shortened dynein arms (HP:0200106) | 1.50315055 |
| 191 | Abnormality of the parietal bone (HP:0002696) | 1.50207428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.02559554 |
| 2 | VRK2 | 3.79398600 |
| 3 | TSSK6 | 3.62067005 |
| 4 | MST4 | 3.45335045 |
| 5 | IRAK3 | 3.19377462 |
| 6 | TTK | 2.98571125 |
| 7 | IRAK4 | 2.96680812 |
| 8 | MST1R | 2.86518949 |
| 9 | MAP3K14 | 2.80642817 |
| 10 | CASK | 2.67315621 |
| 11 | NEK1 | 2.63774112 |
| 12 | TNK2 | 2.63734532 |
| 13 | CDC7 | 2.62780465 |
| 14 | MUSK | 2.55358282 |
| 15 | ACVR1B | 2.50775689 |
| 16 | CDK7 | 2.47798844 |
| 17 | PBK | 2.47046225 |
| 18 | PLK3 | 2.43372350 |
| 19 | EPHA2 | 2.34344948 |
| 20 | MKNK1 | 2.31487274 |
| 21 | GRK1 | 2.28380934 |
| 22 | MKNK2 | 2.13908135 |
| 23 | TRIM28 | 2.10899491 |
| 24 | EIF2AK1 | 2.02314871 |
| 25 | NME1 | 1.94169592 |
| 26 | JAK3 | 1.88104533 |
| 27 | TNIK | 1.87157878 |
| 28 | EIF2AK3 | 1.82642200 |
| 29 | BLK | 1.78497786 |
| 30 | TAF1 | 1.75168254 |
| 31 | WNK3 | 1.73923407 |
| 32 | IKBKE | 1.66362013 |
| 33 | NLK | 1.63995898 |
| 34 | BMPR1B | 1.60386537 |
| 35 | CHUK | 1.60159393 |
| 36 | PLK1 | 1.59691562 |
| 37 | STK16 | 1.59399957 |
| 38 | MAP4K1 | 1.56093008 |
| 39 | LMTK2 | 1.55949473 |
| 40 | BTK | 1.55317813 |
| 41 | MAP3K12 | 1.51404718 |
| 42 | BRSK2 | 1.49659399 |
| 43 | PAK4 | 1.49535557 |
| 44 | IKBKB | 1.48244247 |
| 45 | PLK4 | 1.46704419 |
| 46 | CLK1 | 1.44650697 |
| 47 | CDK4 | 1.43093111 |
| 48 | STK38L | 1.42843083 |
| 49 | TESK1 | 1.40297174 |
| 50 | EPHB1 | 1.38697956 |
| 51 | LIMK1 | 1.38076005 |
| 52 | BMPR2 | 1.34131230 |
| 53 | ERBB4 | 1.33854700 |
| 54 | STK4 | 1.33461196 |
| 55 | YES1 | 1.33424533 |
| 56 | CDK9 | 1.32874602 |
| 57 | TYRO3 | 1.32797784 |
| 58 | STK39 | 1.31200743 |
| 59 | MET | 1.30706386 |
| 60 | STK24 | 1.28728659 |
| 61 | TESK2 | 1.24775305 |
| 62 | PTK6 | 1.23645304 |
| 63 | CDK8 | 1.22863089 |
| 64 | PIK3CG | 1.17390213 |
| 65 | WNK4 | 1.16351785 |
| 66 | MAP2K2 | 1.13961546 |
| 67 | WEE1 | 1.12746476 |
| 68 | TXK | 1.12389186 |
| 69 | BRSK1 | 1.11479847 |
| 70 | MATK | 1.10018723 |
| 71 | MYLK | 1.09605511 |
| 72 | KIT | 1.06381958 |
| 73 | EPHB2 | 1.05687592 |
| 74 | NME2 | 1.03187002 |
| 75 | CDK19 | 0.99092358 |
| 76 | CDK3 | 0.98360620 |
| 77 | STK10 | 0.96576570 |
| 78 | CDK12 | 0.95974313 |
| 79 | TYK2 | 0.95371796 |
| 80 | TBK1 | 0.94010875 |
| 81 | STK3 | 0.93964929 |
| 82 | BRD4 | 0.93625459 |
| 83 | TEC | 0.92961546 |
| 84 | AURKB | 0.92932986 |
| 85 | BCR | 0.92462243 |
| 86 | ADRBK2 | 0.89842603 |
| 87 | PDK2 | 0.89094414 |
| 88 | DYRK3 | 0.86607279 |
| 89 | IRAK1 | 0.86356493 |
| 90 | LATS1 | 0.85039744 |
| 91 | DAPK1 | 0.84824942 |
| 92 | TLK1 | 0.81837856 |
| 93 | PASK | 0.79446395 |
| 94 | EPHA3 | 0.78444286 |
| 95 | FGFR1 | 0.78186214 |
| 96 | EIF2AK2 | 0.77724662 |
| 97 | GRK7 | 0.74672933 |
| 98 | ALK | 0.74024705 |
| 99 | TRIB3 | 0.74003835 |
| 100 | BCKDK | 0.72631882 |
| 101 | MAP3K13 | 0.71952301 |
| 102 | NEK6 | 0.67904781 |
| 103 | NUAK1 | 0.67332542 |
| 104 | CSNK1A1L | 0.66010383 |
| 105 | LYN | 0.64178200 |
| 106 | MAPK3 | 0.63611667 |
| 107 | WNK1 | 0.63515687 |
| 108 | CHEK2 | 0.63251700 |
| 109 | NEK2 | 0.62749441 |
| 110 | SYK | 0.61381135 |
| 111 | OXSR1 | 0.61275309 |
| 112 | AURKA | 0.61066297 |
| 113 | PRKCQ | 0.60999778 |
| 114 | SRPK1 | 0.60879619 |
| 115 | DYRK2 | 0.60698125 |
| 116 | SIK3 | 0.60391493 |
| 117 | VRK1 | 0.57466517 |
| 118 | PIM1 | 0.56979290 |
| 119 | PAK1 | 0.56088179 |
| 120 | ZAK | 0.56000591 |
| 121 | CDC42BPA | 0.55636854 |
| 122 | MAPKAPK5 | 0.55374140 |
| 123 | ABL2 | 0.54852627 |
| 124 | CSNK1G3 | 0.54733501 |
| 125 | ERBB3 | 0.54111751 |
| 126 | CSNK1G1 | 0.54003275 |
| 127 | MAP3K8 | 0.53685193 |
| 128 | PTK2 | 0.52754332 |
| 129 | BRAF | 0.52454800 |
| 130 | ERBB2 | 0.48170955 |
| 131 | PRKCE | 0.48068701 |
| 132 | RPS6KA4 | 0.46777245 |
| 133 | CSNK2A1 | 0.46578372 |
| 134 | CSNK2A2 | 0.46328778 |
| 135 | RPS6KA5 | 0.46102491 |
| 136 | ABL1 | 0.45483601 |
| 137 | TRPM7 | 0.45361856 |
| 138 | MELK | 0.44712932 |
| 139 | ATM | 0.44382916 |
| 140 | LATS2 | 0.42676868 |
| 141 | CSNK1G2 | 0.42606409 |
| 142 | PLK2 | 0.42189701 |
| 143 | MAP2K7 | 0.41984033 |
| 144 | CHEK1 | 0.41088060 |
| 145 | MAPKAPK2 | 0.40408102 |
| 146 | CSNK1A1 | 0.40381088 |
| 147 | PRKCI | 0.40131448 |
| 148 | MAPK13 | 0.39023910 |
| 149 | ATR | 0.38660130 |
| 150 | HCK | 0.38450718 |
| 151 | CSK | 0.38077526 |
| 152 | LCK | 0.34980775 |
| 153 | BMX | 0.34951773 |
| 154 | FES | 0.34619550 |
| 155 | NEK9 | 0.33351890 |
| 156 | CSNK1E | 0.32858247 |
| 157 | TIE1 | 0.32825782 |
| 158 | AKT1 | 0.32105208 |
| 159 | KDR | 0.29622169 |
| 160 | MAP3K5 | 0.28899204 |
| 161 | ARAF | 0.28143682 |
| 162 | FLT3 | 0.26682021 |
| 163 | CDK1 | 0.24184795 |
| 164 | SMG1 | 0.23868741 |
| 165 | MAP3K2 | 0.22449028 |
| 166 | CCNB1 | 0.21252490 |
| 167 | TGFBR1 | 0.19171246 |
| 168 | MINK1 | 0.18726333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.18987937 |
| 2 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.82315403 |
| 3 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 2.71575705 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.47660040 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.37085557 |
| 6 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.18143124 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.11260822 |
| 8 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.06980031 |
| 9 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.05523552 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.99796424 |
| 11 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.92691933 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.91449992 |
| 13 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.86212088 |
| 14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.82595271 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.76518129 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.75345423 |
| 17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.75200099 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.73296135 |
| 19 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.71445315 |
| 20 | RNA transport_Homo sapiens_hsa03013 | 1.71334747 |
| 21 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.69968862 |
| 22 | Ribosome_Homo sapiens_hsa03010 | 1.66992471 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.63564707 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.63004990 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.62842442 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.62090231 |
| 27 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.62076063 |
| 28 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.61789263 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.59569153 |
| 30 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.56025540 |
| 31 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.55499937 |
| 32 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.54455859 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.53923275 |
| 34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.53799725 |
| 35 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.52947681 |
| 36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.51421693 |
| 37 | Protein export_Homo sapiens_hsa03060 | 1.48462778 |
| 38 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.43887342 |
| 39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.43845032 |
| 40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.43012540 |
| 41 | Measles_Homo sapiens_hsa05162 | 1.42343060 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.41745402 |
| 43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40888617 |
| 44 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.39802489 |
| 45 | Leishmaniasis_Homo sapiens_hsa05140 | 1.37458000 |
| 46 | Huntingtons disease_Homo sapiens_hsa05016 | 1.36646581 |
| 47 | Cell cycle_Homo sapiens_hsa04110 | 1.33564252 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33215586 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32623724 |
| 50 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.30464360 |
| 51 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.24774021 |
| 52 | Asthma_Homo sapiens_hsa05310 | 1.24671987 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.24265629 |
| 54 | Homologous recombination_Homo sapiens_hsa03440 | 1.23735933 |
| 55 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.23531870 |
| 56 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.23274393 |
| 57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.23167292 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.22161571 |
| 59 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.22005277 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21948109 |
| 61 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.20539784 |
| 62 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.19875067 |
| 63 | Influenza A_Homo sapiens_hsa05164 | 1.17399990 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.16676680 |
| 65 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15941614 |
| 66 | DNA replication_Homo sapiens_hsa03030 | 1.15310026 |
| 67 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.13654291 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 1.12138736 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.10661455 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.08500491 |
| 71 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.07198339 |
| 72 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.03059588 |
| 73 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.02550196 |
| 74 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.02405203 |
| 75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.01203537 |
| 76 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99489270 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.98133624 |
| 78 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.97214905 |
| 79 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97064398 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96156211 |
| 81 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.95852606 |
| 82 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.95029978 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.94543234 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93503514 |
| 85 | Mismatch repair_Homo sapiens_hsa03430 | 0.92444109 |
| 86 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.91867841 |
| 87 | RNA polymerase_Homo sapiens_hsa03020 | 0.90850949 |
| 88 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.88905504 |
| 89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.88235313 |
| 90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.88219295 |
| 91 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.88170743 |
| 92 | Basal transcription factors_Homo sapiens_hsa03022 | 0.87812395 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.86954776 |
| 94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.86534995 |
| 95 | Pertussis_Homo sapiens_hsa05133 | 0.86344434 |
| 96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86131551 |
| 97 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.85379106 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.84755460 |
| 99 | Base excision repair_Homo sapiens_hsa03410 | 0.83617494 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.82737840 |
| 101 | Legionellosis_Homo sapiens_hsa05134 | 0.82292344 |
| 102 | Malaria_Homo sapiens_hsa05144 | 0.81377134 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81313644 |
| 104 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.78677741 |
| 105 | Metabolic pathways_Homo sapiens_hsa01100 | 0.77687187 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77372362 |
| 107 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.77230380 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76400471 |
| 109 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.74888701 |
| 110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.73100330 |
| 111 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.72485847 |
| 112 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.72351306 |
| 113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.71436958 |
| 114 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70697836 |
| 115 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70647020 |
| 116 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.70463678 |
| 117 | Peroxisome_Homo sapiens_hsa04146 | 0.70323490 |
| 118 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.69635715 |
| 119 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69366912 |
| 120 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69239981 |
| 121 | Sulfur relay system_Homo sapiens_hsa04122 | 0.68534866 |
| 122 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.68020117 |
| 123 | Histidine metabolism_Homo sapiens_hsa00340 | 0.67515669 |
| 124 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67461636 |
| 125 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66438268 |
| 126 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.66334543 |
| 127 | Apoptosis_Homo sapiens_hsa04210 | 0.65237898 |
| 128 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64881278 |
| 129 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64332715 |
| 130 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63822380 |
| 131 | Hepatitis B_Homo sapiens_hsa05161 | 0.63388093 |
| 132 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.62753255 |
| 133 | Prostate cancer_Homo sapiens_hsa05215 | 0.61685525 |
| 134 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61344414 |
| 135 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61311027 |
| 136 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.60992173 |
| 137 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60232738 |
| 138 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60012554 |
| 139 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.59897545 |
| 140 | Pathways in cancer_Homo sapiens_hsa05200 | 0.56770299 |
| 141 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56595598 |
| 142 | Amoebiasis_Homo sapiens_hsa05146 | 0.55634742 |
| 143 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55343426 |
| 144 | Tuberculosis_Homo sapiens_hsa05152 | 0.55219069 |
| 145 | Hepatitis C_Homo sapiens_hsa05160 | 0.55108084 |
| 146 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.54495886 |
| 147 | RNA degradation_Homo sapiens_hsa03018 | 0.53847072 |
| 148 | Salmonella infection_Homo sapiens_hsa05132 | 0.53616254 |
| 149 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53223167 |
| 150 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53164816 |
| 151 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53005121 |
| 152 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52449123 |
| 153 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.52398135 |
| 154 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.52023100 |
| 155 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.51903206 |
| 156 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.51109100 |
| 157 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49699725 |
| 158 | Spliceosome_Homo sapiens_hsa03040 | 0.48407862 |
| 159 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48344677 |
| 160 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47725330 |
| 161 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46766874 |
| 162 | Platelet activation_Homo sapiens_hsa04611 | 0.46081134 |
| 163 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.45798002 |
| 164 | Axon guidance_Homo sapiens_hsa04360 | 0.45552947 |
| 165 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43082322 |
| 166 | Focal adhesion_Homo sapiens_hsa04510 | 0.41719454 |
| 167 | Tight junction_Homo sapiens_hsa04530 | 0.40987155 |
| 168 | Purine metabolism_Homo sapiens_hsa00230 | 0.40473417 |
| 169 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.37553837 |
| 170 | Adherens junction_Homo sapiens_hsa04520 | 0.36602430 |
| 171 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.33841440 |
| 172 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.32311308 |
| 173 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.30115038 |
| 174 | Thyroid cancer_Homo sapiens_hsa05216 | 0.26760980 |

